Recombinant RSV Vaccine (CHO Cell)

recombinant RSV vaccine produced in CHO cells · MAXVAX Biotechnology Limited Liability Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Recombinant RSV Vaccine (CHO Cell), covering 2025-06-06 to 2025-06-06. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Immunogenicity of Recombinant RSV Vaccine (CHO Cell) in Healthy Subjects Aged 18 Years and Above [Phase 1, Phase 2]

See pricing